New Drug Gives Survival Boost to HER2-Positive Breast Cancer Patients

October 1, 2014 6:12 AM

15 0

Latest studies have shown that a drug named Perjeeta provides a surprising extension in survival years for the patients of breast cancer suffering from HER2-positive.

If the drug is added to chemotherapy and Herceptin, another standard medication, it shows significant uplift in survival for breast cancer patients who have been battling with an advanced stage of cancer. Both medications fight tumour cells.

Read more

To category page